Sai Life SciencesNSE:SAILIFE +1.35%18 Net Margin % is 17.31% as of Mar. 2026, which is 204% above its 10-year median of 5.69. GuruFocus rates NSE:SAILIFE with a GF Score™ of 18/100. The stock has 4 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Sai Life Sciences ranks better than 88.24% on this metric.
The historical rank and industry rank for Sai Life Sciences's Net Margin % or its related term are showing as below:
NSE:SAILIFE'
s Net Margin % Range Over the Past 10 Years
Min: 0.72 Med: 5.69 Max: 15.91
Current: 15.91
NSE:SAILIFE's Net Margin % is ranked better than 88.24% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: -2.405
vs NSE:SAILIFE: 15.91
Sai Life Sciences (NSE:SAILIFE) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Sai Life Sciences Net Margin % Related Terms
Sai Life Sciences Net Margin % Historical Data
* Premium members only.
The historical data trend for Sai Life Sciences's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:SAILIFE vs TMO, DHR, IDXX: Net Margin % Comparison
For the Diagnostics & Research subindustry, Sai Life Sciences's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sai Life Sciences Net Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Sai Life Sciences's Net Margin % distribution charts can be found below:
* The bar in red indicates where Sai Life Sciences's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sai Life Sciences (NSE:SAILIFE) has a Net Margin % of 17.31% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Sai Life Sciences and its competitors. This is 204% above median its historical median of 5.69. Over the past decade, Sai Life Sciences' Net Margin % has ranged from 0.72 to 15.91. According to the industry distribution chart, Sai Life Sciences ranks #24 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 11.8%.
Is Sai Life Sciences' Net Margin % too high?
Sai Life Sciences' current Net Margin % of 17.31% is 204% above median its 10-year median of 5.69. Over the past 10 years, this metric has ranged from a low of 0.72 to a high of 15.91. Based on the distribution chart, Sai Life Sciences ranks #24 out of 204 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Sai Life Sciences has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sai Life Sciences' Net Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Sai Life Sciences ranks #24 out of 204 companies for Net Margin %. This places Sai Life Sciences in the top 12% of its industry — outperforming the majority of peers. Historically, Sai Life Sciences' own Net Margin % has ranged from 0.72 to 15.91 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Diagnostics & Research company?
A good Net Margin % depends on the Medical Diagnostics & Research industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Sai Life Sciences and its competitors. Sai Life Sciences's current Net Margin % is 17.31%, which is 204% above median its own 10-year median of 5.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sai Life Sciences stock overvalued right now?
Sai Life Sciences (NSE:SAILIFE) has a current Net Margin % of 17.31%. The current Net Margin % is 17.31%, which is 204% above median its 10-year median of 5.69. Sai Life Sciences' overall GF Score™ is 18/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Sai Life Sciences (NSE:SAILIFE), the current Net Margin % is 17.31% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sai Life Sciences Ltd is an innovator-focused, contract research, development, and manufacturing organization. It provides end-to-end services across the drug discovery, development, and manufacturing value chain, for small molecule new chemical entities (NCE), to pharmaceutical innovator companies and biotechnology firms. It possesses both; discovery/contract research (CRO) and chemistry, manufacturing, and control (CMC)/contract development and manufacturing organization (CDMO) capabilities. The company has only one reportable segment: contract research, development, and manufacturing. Geographically it operates in India as well as Outside India.
18GF Score
Get the complete analysis for NSE:SAILIFE
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SAILIFE has been successfully added to your 
